摘要
背景:寄生虫感染如利什曼病是一种被忽视的热带病,是一个重大的全球负担,造成高死亡率,特别是在欠发达国家。其细胞内的性质和寄生虫的传播位置,有限数量的化学治疗剂,对一线药物和毒性的抵抗力的增加的发生率,对通过调节现有药物的传递而必须有效管理利什曼原虫感染的科学家构成了巨大的挑战。在过去十年中,已经广泛研究了基于纳米技术的药物递送系统(纳米颗粒,纳米悬浮液,脂质体等)等替代疗法的开发研究,天然产物的使用以及开发抗风险疫苗的研究。 目的:本次审查的重点是治疗策略,现有的杂项药物递送系统和旨在管理的方法以及感染治疗的不同方面,目的是总结当前系统地采用的治疗策略趋势和策略。此外,该文章还包含了一系列专利专利,涉及用于抗风湿疗法的新型化疗药物。 结论:报告的杂项新型药物递送系统以及各种方法似乎是精确,安全和相对有效的;在结果中,可能导致利什曼病治疗的新轨迹。
关键词: 利什曼病,治疗策略,纳米载体,纳米颗粒,脂质体,疫苗,天然产物,专利。
图形摘要
Current Drug Targets
Title:Recent Advances in Nanosystems and Strategies for Managing Leishmaniasis
Volume: 18 Issue: 14
关键词: 利什曼病,治疗策略,纳米载体,纳米颗粒,脂质体,疫苗,天然产物,专利。
摘要: Background: Parasitic infection such as leishmaniasis, a neglected tropical disease, presents a significant global burden which is responsible for high mortality rate especially in less developed countries. Its intracellular nature and disseminated locations of parasite, limited number of chemotherapeutic agents, increasing incidences of resistance to first line drugs and toxicities, pose a great challenge to formulation scientists that have necessitated effective management of leishmanial infection by modulating the delivery of existing drugs. Over the past decade, research on development of alternative treatments such as nanotechnology-based drug delivery systems (nanoparticles, nanosuspensions, liposomes etc.), use of natural products as well as development of antileishmanial vaccine has been extensively investigated.
Objective: The present review focuses on different facets of therapeutic strategies, existing miscellaneous drug delivery systems and approaches intended for management, as well as treatment of the infection, with an objective to summarize the current trends and strategies adopted for antileishmanial therapy in a systematic manner. Moreover, the article encloses an eclectic collection of patents allied to new-fangled chemotherapeutics for antileishmanial therapy.
Conclusion: The reported miscellaneous novel drug delivery systems along with the diverse approaches are seem to be precise, secure and relatively effective; and in an outcome, could lead to the new track for management of leishmaniasis.
Export Options
About this article
Cite this article as:
Recent Advances in Nanosystems and Strategies for Managing Leishmaniasis, Current Drug Targets 2017; 18 (14) . https://dx.doi.org/10.2174/1389450117666160401124133
DOI https://dx.doi.org/10.2174/1389450117666160401124133 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Clinical Application of PET Myocardial Perfusion Imaging
Current Medical Imaging Inflammatory Related Cardiovascular Diseases: From Molecular Mechanisms to Therapeutic Targets
Current Pharmaceutical Design Advances in the Understanding of the Gabaergic Neurobiology of FMR1 Expanded Alleles Leading to Targeted Treatments for Fragile X Spectrum Disorder
Current Pharmaceutical Design Potential of Resveratrol in Preventing the Development of Heart Failure
Current Chemical Biology Gut Microbiota and Cardiovascular Disease: Symbiosis Versus Dysbiosis
Current Medicinal Chemistry Molecular Dynamics as a Tool in Rational Drug Design: Current Status and Some Major Applications
Current Computer-Aided Drug Design Role of Innate Immune System in Inflammation and Cardiac Remodeling After Myocardial Infarction
Current Vascular Pharmacology New Insights into the Surgical Management of Tetralogy of Fallot: Physiological Fundamentals and Clinical Relevance
Current Pediatric Reviews From Na+/K+-ATPase and Cardiac Glycosides to Cytotoxicity and Cancer Treatment
Anti-Cancer Agents in Medicinal Chemistry Resveratrol and Ischemic Preconditioning in the Brain
Current Medicinal Chemistry Editorial [Hot Topic Intracellular Calcium Signaling: Holding the Balance between Health and Disease Guest Editor: Luca Munaron]
Current Medicinal Chemistry The Role of Atypical Antipsychotic Agents in the Treatment of Schizophrenia and Schizoaffective Disorders in the Elderly
Current Drug Safety The Na+/H+ Exchanger: A Target for Cardiac Therapeutic Intervention
Current Drug Targets - Cardiovascular & Hematological Disorders New Therapeutic Aspects of Inflammatory Cardiomyopathy
Current Pharmaceutical Design Safety of Systemic Biologic Agents in the Treatment of Non-malignant Skin Disorders
Current Drug Safety Bedtime Hypertension Chronotherapy: Concepts and Patient Outcomes
Current Pharmaceutical Design Pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidines and Structurally Simplified Analogs. Chemistry and SAR Profile as Adenosine Receptor Antagonists
Current Topics in Medicinal Chemistry Stereoselectivity in Drug Metabolism: Molecular Mechanisms and Analytical Methods
Current Drug Metabolism Evaluation of the Cardioprotective Effect of Granulocyte Colony Stimulating Factor in Patients with Carbon Monoxide Poisoning
Protein & Peptide Letters Treating Heart Failure with Preserved Ejection Fraction Related to Arterial Stiffness. Can we Kill Two Birds With One Stone?
Current Vascular Pharmacology